Does PAZOPANIB Cause Benign prostatic hyperplasia? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Benign prostatic hyperplasia have been filed in association with PAZOPANIB (Pazopanib). This represents 0.1% of all adverse event reports for PAZOPANIB.
12
Reports of Benign prostatic hyperplasia with PAZOPANIB
0.1%
of all PAZOPANIB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From PAZOPANIB?
Of the 12 reports, 2 (16.7%) resulted in death, 10 (83.3%) required hospitalization.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which PAZOPANIB Alternatives Have Lower Benign prostatic hyperplasia Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS